Proventis is developing a long-term, reversible implant for male contraception. The implant is intended to provide reliable contraceptive protection without requiring daily attention or interrupting routine activities. It can be placed by a physician in a brief, minimally invasive in-office procedure and later deactivated to restore fertility. The company focuses on advancing reproductive health through scientific research and collaborations with urologists, medical experts, and investors in the field of male contraceptives.